Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ching-Feng Chiu
TARBP2-mediated Destabilization of Nanog Overcomes Sorafenib Resistance in Hepatocellular Carcinoma
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Related publications
Treatment With a New Benzimidazole Derivative Bearing a Pyrrolidine Side Chain Overcomes Sorafenib Resistance in Hepatocellular Carcinoma
Scientific Reports
Multidisciplinary
In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance Through Inhibition of Caspase-3–Mediated Apoptosis
Clinical Cancer Research
Cancer Research
Oncology
Sorafenib in Hepatocellular Carcinoma
Clinical Medicine. Therapeutics
The Microenvironmental and Metabolic Aspects of Sorafenib Resistance in Hepatocellular Carcinoma
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
Cytotoxicity of Sorafenib in Human Hepatocellular Carcinoma Cells
Al-Azhar Journal of Pharmaceutical Sciences
TGFβ Signaling Confers Sorafenib Resistance via Induction of Multiple RTKs in Hepatocellular Carcinoma Cells
Molecular Carcinogenesis
Cancer Research
Molecular Biology
MicroRNA‑223 Promotes Hepatocellular Carcinoma Cell Resistance to Sorafenib by Targeting FBW7
Oncology Reports
Medicine
Cancer Research
Oncology
Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma
Journal of Liver Research, Disorders & Therapy
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy